PeptiSystems
Improving synthesis of drug molecules
- CEO: Karin Granath
- First investment year: 2019
- Fund: Östra Mellansverige
- Business sector: Life Science
R&D, manufacturing and supply of instruments used for solid phase synthesis of peptide and oligonucleotide therapeutics.